logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available [see all tables in this series...]

Part (i) Demographics

CountryYearNo. of clientsMean age% Age <25% Age 35+% Male
Bulgaria200538822.473.51.382.2
Czech Republic2005437222.968.66.268.2
Denmark2005157827.547.820.275.4
Germany20051403325.162.311.582.0
Ireland2005200726.957.79.778.9
Greece2005222529.536.119.084.5
Spain(1)20042616929.534.826.982.5
France2005416724.262.89.682.1
Italy20053517530.029.530.186.3
Cyprus200520926.149.315.885.6
Latvia200540122.269.69.576.0
Lithuania200534926.346.413.278.2
Luxembourg(2)200538330.070.0
Hungary2005631925.255.013.074.0
Malta200531223.567.610.983.0
Netherlands2005429928.840.226.078.7
Austria200587326.450.916.3
Poland(1)2004694026.061.317.476.0
Portugal2005484431.020.736.085.3
Romania200565332.352.023.070.0
Slovenia(1)200452623.168.05.075.6
Slovakia200596323.769.76.780.2
Finland200563124.464.011.068.0
Sweden2005133731.739.534.164.3
United Kingdom20054292329.437.025.771.5
Turkey200593927.940.020.092.3

Notes:

 Data were not available for: Belgium, Estonia, Norway. 

 (1) Last data available refer to 2004. 

 (2) Data refer to all clients in treatment. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Standard table 3 See [Table TDI-1] for details on sources. 

Page last updated: Monday, 12 November 2007